Working under the umbrella of the PsychENCODE Consortium, the mental health research project established in 2015 by the National Institutes of Health, a team of Mount Sinai scientists has uncovered important new insights into the molecular biology of neuropsychiatric disease through two new studies published in a special issue of Science on Friday, May 24.
Eight evolving patient communication risks in pharma and biotech – Pharmaceutical Technology
Share this article In the world of pharmaceuticals and biotechnology, the journey from research and development to delivering life-saving medications is a complex and delicate process.